FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileCardioGenics Holdings Inc
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
CGNH
CardioGenics Holdings Inc Stock AnalysisComprehensive stock analysis for CardioGenics Holdings Inc (CGNH) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisCGNH
CGNH
CardioGenics Holdings Inc
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
CGNH
  1. Home
  2. Stocks
  3. CardioGenics Holdings Inc
CG

CardioGenics Holdings Inc

🇺🇸CGNH•OTC
CG

CardioGenics Holdings Inc

🇺🇸CGNH•OTC
Market cap
$12.00K

Your view on CGNH

Mkt Cap
$12.00K
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About CardioGenics Holdings Inc

Industry
Medical - Diagnostics & Research
Sector
Healthcare
CEO
Yahia Abdul Gawad
Headquarters
6295 Northam Drive, Mississauga, ON, CA
Industry
Medical - Diagnostics & Research
Sector
Healthcare
CEO
Yahia Abdul Gawad
Headquarters
6295 Northam Drive, Mississauga, ON, CA
Description

CardioGenics Holdings Inc. engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market in the United States, Canada, Europe, and internationally.

Its products include QL Care Analyzer, a portable, stand-alone, and automated point-of-care (POC) immunoassay analyzer that uses a proprietary self-metering cartridge to perform immunoassay tests at the POC; a series of immunoassay tests to identify cardiac markers in the blood at the time of a heart attack; and paramagnetic beads that are used as solid surfaces in heterogeneous immunoassay tests by clinical and research laboratories.

The company was formerly known as Jag Media Holdings, Inc. and changed its name to CardioGenics Holdings Inc. in 2009. The company was founded in 1997 and is headquartered in Mississauga, Canada.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for CardioGenics Holdings Inc. Starting points for CardioGenics Holdings Inc: EPS -$0.02, beta 20.77 — an Medical - Diagnostics & Research name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for CardioGenics Holdings Inc. CardioGenics Holdings Inc does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for CardioGenics Holdings Inc. Trailing twelve-month EPS for CardioGenics Holdings Inc stands at -$0.02. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for CardioGenics Holdings Inc. CardioGenics Holdings Inc has reported as a listed company since 2004. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold CGNH12 companies
More Medical - Diagnostics & Research companies
TickerTypeCompanySectorExchangeMkt cap
WGSGeneDx Holdings Corp.HealthcareNASDAQ$1.4B
WUXAYWuXi AppTec Co., Ltd.HealthcareOTC$45.6B
WUXIFWuXi AppTec Co., Ltd.HealthcareOTC$39.8B
XGNExagen Inc.HealthcareNASDAQ$92.1M
SKHHYSonic Healthcare LimitedHealthcareOTC$8.2B
SLDXStella Diagnostics Inc.HealthcareOTC$1.4M
SPDESpeedus Corp.HealthcareOTC$416
SZLSFStageZero Life Sciences Ltd.HealthcareOTC$61,766
TDSGFTelo Genomics Corp.HealthcareOTC$3.8M
TELO.VTelo Genomics Corp.HealthcareTSXV$4.0M
THOXFBioPorto A/SHealthcareOTC$73.8M
TMOThermo Fisher Scientific Inc.HealthcareNYSE$248.1B
Ownership & News

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for CardioGenics Holdings Inc. Coverage tracks CardioGenics Holdings Inc within Medical - Diagnostics & Research (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of CardioGenics Holdings Inc.

CGNH AnalysisWeak
Past
2
Growth
1
Health
1
Profit
1
Value
1